Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells

H. Ding, K. L. Peterson, C. Correia, B. Koh, P. A. Schneider, G. S. Nowakowski, S. H. Kaufmann

Research output: Contribution to journal › Article › peer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Histone deacetylase inhibitors interrupt HSP90•RASGRP1 and HSP90•CRAF interactions to upregulate BIM and circumvent drug resistance in lymphoma cells'. Together they form a unique fingerprint.

Medicine & Life Sciences